M Moorghen

Author PubWeight™ 20.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 BCL-2 expression in human colorectal adenomas and carcinomas. Oncogene 1994 1.34
2 Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells. Cancer Res 2000 1.12
3 Characterisation of adherens and tight junctional molecules in normal animal larynx; determining a suitable model for studying molecular abnormalities in human laryngopharyngeal reflux. J Clin Pathol 2005 1.10
4 Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study. Gut 2000 1.06
5 TGF-beta expression in the human colon: differential immunostaining along crypt epithelium. Br J Cancer 1993 1.02
6 Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis. Aliment Pharmacol Ther 2003 0.99
7 Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence. Gut 1994 0.99
8 The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells. Oncogene 2010 0.95
9 Primary yolk sac tumour of the liver in adulthood. J Clin Pathol 1998 0.94
10 Plexiform neurofibroma of the small bowel infiltrated with metastatic adenocarcinoma. Br J Radiol 1999 0.91
11 Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: possibilities for combination therapy. Cell Prolif 2007 0.90
12 Epstein-Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomas. J Pathol 2003 0.90
13 c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus. J Clin Pathol 1995 0.87
14 Transcriptional down-regulation of the retinoblastoma protein is associated with differentiation and apoptosis in human colorectal epithelial cells. Br J Cancer 2001 0.85
15 Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease. Aliment Pharmacol Ther 2006 0.85
16 Upper gastrointestinal cancer pathology reporting: a regional audit to compare standards with minimum datasets. J Clin Pathol 2004 0.84
17 The role of the retinoblastoma protein (Rb) in the nuclear localization of BAG-1: implications for colorectal tumour cell survival. Biochem Soc Trans 2005 0.81
18 Configurational changes within the dermis of meshed split skin grafts: a histological study. Br J Plast Surg 1987 0.80
19 Modulation by verapamil of vincristine pharmacokinetics and sensitivity to metaphase arrest of the normal rat colon in organ culture. Biochem Pharmacol 1991 0.80
20 Cost-effective strategy for the serological investigation of coeliac disease. Ann Clin Biochem 2000 0.78
21 Effects of gastrointestinal peptides on azoxymethane-treated colonic mucosa in vitro. Carcinogenesis 1991 0.78
22 Difficulty in diagnosing complications of Caroli's disease. J Clin Gastroenterol 1986 0.76
23 Verapamil sensitizes normal and neoplastic rodent intestinal tissues to the stathmokinetic effect of vincristine in vivo. Br J Cancer 1988 0.75